167 related articles for article (PubMed ID: 35456281)
1. Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales.
Diez Porras L; Homedes C; Alberti MA; Velez Santamaria V; Casasnovas C
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456281
[TBL] [Abstract][Full Text] [Related]
2. Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Andersen H; Mantegazza R; Wang JJ; O'Brien F; Patra K; Howard JF;
Qual Life Res; 2019 Aug; 28(8):2247-2254. PubMed ID: 30905021
[TBL] [Abstract][Full Text] [Related]
3. Reduced quality of life in myasthenia gravis patients: A study on 185 patients from China.
Wu X; Li RY; Ye XB; Wang N
Front Neurol; 2022; 13():1072861. PubMed ID: 36712441
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study.
Thomsen JLS; Vinge L; Harbo T; Andersen H
Muscle Nerve; 2021 Nov; 64(5):538-544. PubMed ID: 34036597
[TBL] [Abstract][Full Text] [Related]
5. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
Burns TM; Sadjadi R; Utsugisawa K; Gwathmey KG; Joshi A; Jones S; Bril V; Barnett C; Guptill JT; Sanders DB; Hobson-Webb L; Juel VC; Massey J; Gable KL; Silvestri NJ; Wolfe G; Cutter G; Nagane Y; Murai H; Masuda M; Farrugia ME; Carmichael C; Birnbaum S; Hogrel JY; Nafissi S; Fatehi F; Ou C; Liu W; Conaway M
Muscle Nerve; 2016 Dec; 54(6):1015-1022. PubMed ID: 27220659
[TBL] [Abstract][Full Text] [Related]
6. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
Burns TM; Conaway MR; Cutter GR; Sanders DB;
Muscle Nerve; 2008 Aug; 38(2):957-63. PubMed ID: 18642357
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
[TBL] [Abstract][Full Text] [Related]
8. A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis.
Thomsen JLS; Vinge L; Harbo T; Andersen H
Neuromuscul Disord; 2022 Apr; 32(4):305-312. PubMed ID: 35279342
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version.
Ostovan VR; Fatehi F; Davoudi F; Nafissi S
Muscle Nerve; 2016 Jun; 54(1):65-70. PubMed ID: 26661455
[TBL] [Abstract][Full Text] [Related]
10. The myasthenia gravis--specific activities of daily living profile.
Muppidi S
Ann N Y Acad Sci; 2012 Dec; 1274():114-9. PubMed ID: 23252905
[TBL] [Abstract][Full Text] [Related]
11. Validation of myasthenia gravis activity of daily living questionnaire: Persian version.
Faghani S; Okhvat AA; Karimi N; Moassefi M; Maroufi SF; Nafissi S; Fatehi F
Curr J Neurol; 2022 Jan; 21(1):35-39. PubMed ID: 38011442
[No Abstract] [Full Text] [Related]
12. Validation of Spanish version of 15-item myasthenia gravis quality-of-life questionnaire.
Contreras JP; Salinas R; Vidal C; Hoffmeister L; Wolfe GI; Cea G
Acta Neurol Scand; 2021 Nov; 144(5):546-552. PubMed ID: 34131909
[TBL] [Abstract][Full Text] [Related]
13. Construct and concurrent validation of the MG-QOL15 in the practice setting.
Burns TM; Grouse CK; Conaway MR; Sanders DB;
Muscle Nerve; 2010 Feb; 41(2):219-26. PubMed ID: 19941339
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of the Turkish version of myastheniagravis-quality of life questionnaire-15 item.
Taşcilar NF; Saraçli Ö; Kurçer MA; Ankarali H; Emre U
Turk J Med Sci; 2016 Jun; 46(4):1107-13. PubMed ID: 27513412
[TBL] [Abstract][Full Text] [Related]
15. Disease Severity Assessment and Short-Term Outcome in Patients with Myasthenia Gravis.
Vemuri D; Garuda BR; Gopi S; Kumar TS; Kumari UA
Ann Indian Acad Neurol; 2020; 23(2):215-219. PubMed ID: 32189865
[TBL] [Abstract][Full Text] [Related]
16. The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
Farrugia ME; Carmichael C; Cupka BJ; Warder J; Brennan KM; Burns TM
Muscle Nerve; 2014 Oct; 50(4):501-7. PubMed ID: 24639179
[TBL] [Abstract][Full Text] [Related]
17. Developing outcome measures of disease activity in pediatric myasthenia.
Prior DE; Cooper BA; Zhang B; Ghosh PS
Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
[TBL] [Abstract][Full Text] [Related]
18. Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.
Raggi A; Leonardi M; Ayadi R; Antozzi C; Maggi L; Baggi F; Mantegazza R
Muscle Nerve; 2017 Oct; 56(4):716-720. PubMed ID: 28029697
[TBL] [Abstract][Full Text] [Related]
19. Validity and reliability of the Polish version of myasthenia gravis - Quality of life questionnaire - 15 item.
Rozmilowska I; Adamczyk-Sowa M; Pierzchala K; Czyzewski D
Neurol Neurochir Pol; 2017; 51(4):311-318. PubMed ID: 28579082
[TBL] [Abstract][Full Text] [Related]
20. Patient-acceptable symptom states in myasthenia gravis.
Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C
Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
